Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.
Tolerance Bio's investors include Columbus Venture Partners, BioAdvance, Ben Franklin Technology Partners of Northeastern Pennsylvania, Criteria Bio Ventures, Beyond Celiac Investments.
Tolerance Bio is headquartered in Philadelphia, United States.
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.
Tolerance Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tolerance Bio — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/tolerance-bio. Accessed September 15, 2026.
VCBacked. (2026). Tolerance Bio — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/tolerance-bio
{{cite web |title=Tolerance Bio — Funding & Investors |url=https://www.vcbacked.co/company/tolerance-bio |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated